CVA Family Office’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $28.3K | Buy |
|
|||||
|
2025
Q2 | $19.9K | Buy |
|
|||||
|
2025
Q1 | $9.99K | Buy |
|
|||||
|
2024
Q4 | $5.88K | Buy |
|
|||||
|
2024
Q3 | $1.65K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $448 | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $2.85K | Hold |
|
|||||
|
2023
Q1 | $3K | Buy |
|
|||||
|
2022
Q4 | $2.38K | Buy |
|
|||||
|
2022
Q3 | $1K | Sell |
|
|||||
|
2022
Q2 | $1K | Hold |
|
|||||
|
2022
Q1 | $2K | Buy |
|